Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Using the ATM or
View:
Post by Lesalpes29 on Nov 11, 2022 1:13pm

Using the ATM or

What!
Comment by Lesalpes29 on Nov 11, 2022 1:29pm
It seems... thank you Matt!... you just stop a good run. Have a gooooood week-end!
Comment by Kswdelux on Nov 11, 2022 2:59pm
ONC is not using the ATM. Nothing goes straight up for ever, there are always profit taking cycles. ONC has $32M in the bank. That was in the last quarter financials a week ago. They do not need cash. News is all solid... more discussion at KOL on Monday. A deal of some sort is on the way...  Hipe that helps...   
Comment by Kswdelux on Nov 11, 2022 3:00pm
ONC is not using the ATM. Nothing goes straight up for ever, there are always profit taking cycles. ONC has $32M in the bank. That was in the last quarter financials a week ago. They do not need cash. News is all solid... more discussion at KOL on Monday. A deal of some sort is on the way...@ Hipe that helps...@ @
Comment by Lesalpes29 on Nov 11, 2022 3:20pm
Sorry. Shares count seems to change on the up. Probably I'm wrong. Thank you.
Comment by fox7mf on Nov 11, 2022 4:43pm
I notice the float/outstanding share count changing as well. TMX had Onc outstanding shares @ 58.5m a few days ago, they now report just over 59m. Market Place says the float is still 58.5m, so who knows...
Comment by Lesalpes29 on Nov 11, 2022 4:47pm
57.7 to 59.03 on stockhouse quote. Yes who knows!
Comment by Proboscises on Nov 11, 2022 6:23pm
You can find the shares outstanding as of Nov. 3, 2022.  The numbers are on the bottom of page 11 of the Nov. 7 MD&A-English found on SEDAR. Nov. 3, 2022 Shares outstanding:  59,028,688 Nov. 3 2022 Fully Diluted shares:  64,388,508
Comment by westcoast1000 on Nov 13, 2022 1:40pm
Thanks to Prob for the share count numbers. There is no further informaiton on share counts to confirm that the company has been selling via the ATM. They do not release share count numbers on a daily or monthly basis. They do that with quarterly financials. 
Comment by canadafan on Nov 13, 2022 3:29pm
I agree with Westcoast The share co7nts are released quarterly & always a few months behind. did they use ATM within recent run up? Who cares. that conversation is a red herring. Onc must raise $$ to stay in business. they have zero debt. The important question? how soon can they partner o4 be bought out.  We will have a lot more clarity afte4 KOL Dont think fo4 a second to ...more  
Comment by Kswdelux on Nov 14, 2022 12:29pm
FYI: I was looking at the ONC share count a while back when all my warrants expired. And at that time I noticed that the total share numbers shown on STOCKHOUSE and the other websites were all different than what was shown in the ONC website and financials. They all seemed to vary with different numbers on different sites. I though very wierd at the time, sI have no idead why, but I no longer put ...more  
Comment by Hcallahan44 on Nov 14, 2022 1:10pm
Thanks...always appreciate your detailed posts....but when is all this going to happen???? how much longer do us longs have to wait to see some stock appreciation?   it seems its always a year away....
Comment by Buckhenry on Nov 14, 2022 1:18pm
this stock has the "FREE BEER TOMORROW" syndrome..... tomorrow never comes.
Comment by Hcallahan44 on Nov 14, 2022 3:21pm
Too bad you blocked me Buck Henry...i agree wholeheartedly
Comment by Capitalista on Nov 14, 2022 1:22pm
HC44 - IMHO, we won't get any stock price appreciation until ONC takes these great study results and turns them in to great (transformational) business results - either a buyout or a solid partnership deal for Phase III programs.  The market seems to be tired of hearing wonderful study stats without seeing management capitalize on them and turn them into something that would push the ...more  
Comment by Hcallahan44 on Nov 14, 2022 1:30pm
Thanks Capitalista for this sobeing assessment....this has been the worst investment of my life......i went in big here based on a lot of the nonsense that gets posted on this board....I only have myself to blame....meanwhile SAVA is running like a scalded dog....i am stuck in cement overshoes because i am so far underwater......I dont know what Noteable and Canada are smoking...but it must be ...more  
Comment by Kswdelux on Nov 14, 2022 6:40pm
HC,  I was just talking with friend last night about ONC when ONC was still working with dogs. And how I remember the very first Phase I trial report where ONC had just completed the very first single dose injection into humans in the first human tumour ever and took pictures of the tumour with a measuring device in the photo. Then a week later or what ever the time period was, ONC ...more  
Comment by Kswdelux on Nov 14, 2022 6:57pm
Oh, ONC has stated AWARE-1 final data wil be released Q4 2022, so that is due within the next 6 weeks. I thought that was coming with this last presentation, but... soon.  And we should know the bio-marker data at that time. IMHO the science is there. Go read all the last NRs. I am not making this up. Good luck!
Comment by m00nsh0ts on Nov 14, 2022 7:07pm
Fabulous post! You should send it over to Stocktwits.
Comment by westcoast1000 on Nov 14, 2022 7:29pm
Thanks for the encouraging post while the stock is down after great news.  ksw has stated things very well here, with the memories going back to the dog days, and through to the history post 2016 up to today. I have always wondered what we needed to do to verify the biomarkers. That is a tricky question in terms of hypothesis testing, or so it seems. 
Comment by Kswdelux on Nov 14, 2022 7:53pm
  if you look back through NRs after they were well into AWARE-1, when ONC announced the GOBLET, in the NR, ONC kind of slipped the beans on the biomarkers stating, they wanted to see if the same potential biomarkers that they noted for mBC existed for Gastro. The FDA would not have allowed the GOBLET trial if the resutls in other indications were poor. And Roche would not be ...more  
Comment by jimsenior on Nov 14, 2022 8:04pm
Thank you for your posts. This question is likely naive; given GOBLET is with AIO and I think not on clinicaltrials.gov how does the FDA involvement happen. TIA
Comment by Kswdelux on Nov 14, 2022 8:29pm
  Iit is my understaning that AIO is a worldly recognized facility and the data is transferable back to the USA and other countries.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities